Dimensional Fund Advisors
COYA icon

Dimensional Fund Advisors’s Coya Therapeutics COYA Stock Holding History

Dimensional Fund Advisors’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$377K Buy
95,919
+64,490
+205% +$302K ﹤0.01% 2985
2025
Q4 		$182K Buy
31,429
+11,648
+59% +$70.8K ﹤0.01% 3098
2025
Q3 		$113K Hold
19,781
– – ﹤0.01% 3179
2025
Q2 		$114K Buy
+19,781
New +$115K ﹤0.01% 3172

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Dimensional Fund Advisors's COYA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Coya Therapeutics (COYA) stake by 205% in Q1 2026, buying an estimated $302K and bringing the position to 95,919 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

Dimensional Fund Advisors first reported a position in COYA in Q2 2025 and has held it in 4 quarters since. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Dimensional Fund Advisors held 95,919 shares of Coya Therapeutics worth $377K as of Q1 2026.
  • Dimensional Fund Advisors bought 64,490 Coya Therapeutics shares in Q1 2026, an estimated $302K.
  • Coya Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2985 holding.
  • Dimensional Fund Advisors first reported a position in Coya Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.